LiquidiavsMerck & Company

LQDA and MRK stock compared: price, dividend, valuation and results, from SEC filings.

LQDA

Liquidia Corporation

$57.16

Value $5.0B

+0.76%
LQDA's page

MRK

Merck & Company, Inc.

$139.66

Value $345B

-2.62%
MRK's page

Liquidia (LQDA) has a market value of $5.0B and Merck & Company (MRK) $345B. Over the last year, with dividends, LQDA moved +101.3% and MRK +54.8%. Dividend yield: LQDA none, MRK 2.43%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LQDA$5.0B

    MRK$345B

    MRK is 69 times LQDA

  • Revenue, 12 months

    LQDA$622M

    MRK$67.4B

    MRK is 108 times LQDA

  • Net income, 12 months

    LQDA-$94M

    MRK$2.5B

  • Operating margin

    LQDA-15.6%

    MRK–

  • ROIC

    LQDA-110.7%

    MRK3.9%

    114.6 points apart

  • P/E

    LQDA–

    MRK140.8

  • Dividend yield

    LQDA0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    LQDA+1,131.9%

    MRK+96.9%

    1,035.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LQDA+1,131.9%

MRK+96.9%

01000200020222023202420252026
Returns by period
PeriodLQDAWith dividendsMRKWith dividends
1 year since November 17, 2025+101.3%Price +101.3%+54.8%Price +50.4%
3 years since November 17, 2023+803.0%+108.2% a yearPrice +803.0%+50.4%+14.6% a yearPrice +37.2%
5 years since November 17, 2021+1,131.9%+65.2% a yearPrice +1,131.9%+96.9%+14.5% a yearPrice +69.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LQDALiquidiaMRKMerck & Company

Valuation

LQDAMRK
Valuation
Price$57.16$139.66
Market value$5.0B$345B
Enterprise value (EV)–$389B
P/E–140.8
P/E, 5-year median–14.8
P/B–7.7
EV/EBIT–81.8
Free cash flow yield5.8%4.3%

Results and growth

LQDAMRK
Results and growth
Revenue, 12 months$622M$67.4B
Net income, 12 months-$94M$2.5B
Free cash flow, 12 months$291M$14.7B
Earnings per share, 12 months-$1.21$0.98
Revenue growth, year on year1,031.2%1.3%
Revenue growth a year, past+192.5%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

LQDAMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin-15.6%–
Net margin-15.2%3.6%
ROIC-110.7%3.9%
ROE-136.5%5.2%

Balance sheet

LQDAMRK
Balance sheet
Cash$396M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover-3.6×2.4×

Dividends and buybacks

LQDAMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LQDA or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Liquidia or Merck & Company?

By market value, Merck & Company ($345B) is about 68.6 times Liquidia ($5.0B), at today's prices.

How did LQDA and MRK stock do over the last 5 years?

Since November 17, 2021, LQDA's price moved +1,131.9% and MRK's +69.0%. With dividends: LQDA +1,131.9% (+65.2% a year), MRK +96.9% (+14.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, LQDA or MRK?

The dividend yield at today's price is none for Liquidia and 2.43% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Liquidia or Merck & Company?

Over the last twelve months, the net margin was -15.2% for Liquidia and 3.6% for Merck & Company, and the operating margin -15.6% and –. Revenue was $622M and $67.4B.

Which is the better investment, Liquidia or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.